Literature DB >> 17616812

Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.

Ran Zhang1, Naren L Banik, Swapan K Ray.   

Abstract

Phosphatase and tension homolog located on chromosome ten (PTEN) is a tumor suppressor as it negatively regulates activation of Akt. Mutation or deletion of PTEN has been found in as high as 80% of glioblastomas, which harbor aberrant cell signaling passing through the phosphatidylinositol-3-kinase (PI3K) and Akt (PI3K/Akt) survival pathway. Glioblastoma cells without functional PTEN are not easily amenable to apoptosis. We investigated the possibility of modulation of signal transduction pathways for induction of apoptosis in human glioblastoma T98G (PTEN-harboring) and U87MG (PTEN-deficient) cell lines after treatment with the combination of all-trans retinoic acid (ATRA) and interferon-gamma (IFN-gamma). Treatment with ATRA plus IFN-gamma stimulated PTEN expression and suppressed Akt activation in T98G cells, whereas no PTEN expression but Akt activation in U87MG cells under the same conditions. Pretreatment of U87MG cells with the PI3K inhibitor LY294002 could prevent Akt activation. Interestingly, ATRA plus IFN-gamma could significantly decrease cell viability and increase morphological features of apoptosis in both cell lines. Combination of ATRA and IFN-gamma showed more efficacy than IFN-gamma alone in causing apoptosis that occurred due to increases in Bax:Bcl-2 ratio, mitochondrial release of cytochrome c, and caspase-3 activity. Luciferase reporter gene assay showed that combination of ATRA and IFN-gamma significantly down regulated transcriptional activity of the nuclear factor kappa B (NF-kappaB), a survival signaling factor, in U87MG cells. Thus, combination of ATRA and IFN-gamma caused significant amounts of apoptosis in T98G cells due to suppression of the PI3K/Akt survival pathway while the same treatment caused apoptosis in U87MG cells due to down regulation of the NF-kappaB activity. Therefore, the combination of ATRA and IFN-gamma could modulate different survival signal transduction pathways for induction of apoptosis and should be considered as an effective therapeutic strategy for controlling the growth of both PTEN-harboring and PTEN-deficient glioblastomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616812     DOI: 10.1007/s11064-007-9417-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Nuclear factor-kappaB and cell survival: IAPs call for support.

Authors:  R Lee; T Collins
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

2.  Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.

Authors:  Azizul Haque; Arabinda Das; Laela M Hajiaghamohseni; Austin Younger; Naren L Banik; Swapan K Ray
Journal:  Cancer Immunol Immunother       Date:  2006-09-01       Impact factor: 6.968

Review 3.  Targeting malignant glioma survival signalling to improve clinical outcomes.

Authors:  Michael L H Wong; Andrew H Kaye; Christopher M Hovens
Journal:  J Clin Neurosci       Date:  2007-02-01       Impact factor: 1.961

4.  Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene.

Authors:  P H Hwang; H K Yi; D S Kim; S Y Nam; J S Kim; D Y Lee
Journal:  Cancer Lett       Date:  2001-10-22       Impact factor: 8.679

5.  Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.

Authors:  K Kurose; X P Zhou; T Araki; S A Cannistra; E R Maher; C Eng
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

6.  PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma.

Authors:  Yuan Rong; Dawn E Post; Russell O Pieper; Donald L Durden; Erwin G Van Meir; Daniel J Brat
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

Review 7.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

8.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

9.  Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.

Authors:  Dimpy Koul; Ruijun Shen; Sherry Bergh; Xiaoyang Sheng; Shishir Shishodia; Tiffany A Lafortune; Yiling Lu; John F de Groot; Gordon B Mills; W K Alfred Yung
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

10.  Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.

Authors:  Arabinda Das; Naren L Banik; Sunil J Patel; Swapan K Ray
Journal:  Mol Cancer       Date:  2004-12-08       Impact factor: 27.401

View more
  18 in total

1.  Β-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells.

Authors:  Yong-Shun Zhao; Ting-Zhun Zhu; Yan-Wei Chen; Yi-Qun Yao; Chun-Ming Wu; Zhen-Qing Wei; Wei Wang; Ying-Hui Xu
Journal:  J Neurooncol       Date:  2011-12-11       Impact factor: 4.130

2.  Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.

Authors:  Ran Zhang; Naren L Banik; Swapan K Ray
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

Review 3.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

Review 4.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

5.  IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.

Authors:  Qinglin Liu; Gang Li; Ronghui Li; Jie Shen; Qiaowei He; Lin Deng; Cai Zhang; Jian Zhang
Journal:  J Neurooncol       Date:  2010-04-02       Impact factor: 4.130

6.  Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft.

Authors:  Surajit Karmakar; Subhasree Roy Choudhury; Naren L Banik; Swapan K Ray
Journal:  J Cancer Sci Ther       Date:  2010-06-26

7.  Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation.

Authors:  Cheng-Yi Chang; Chiung-Chyi Shen; Hong-Lin Su; Chun-Jung Chen
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

8.  Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.

Authors:  Tsuyoshi Fukushima; Makiko Kawaguchi; Kenji Yorita; Hiroyuki Tanaka; Hideo Takeshima; Kazuo Umezawa; Hiroaki Kataoka
Journal:  Neuro Oncol       Date:  2011-10-03       Impact factor: 12.300

9.  Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.

Authors:  M Ying; S Wang; Y Sang; P Sun; B Lal; C R Goodwin; H Guerrero-Cazares; A Quinones-Hinojosa; J Laterra; S Xia
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

10.  Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo.

Authors:  Lei Han; An-ling Zhang; Peng Xu; Xiao Yue; Yang Yang; Guang-xiu Wang; Zhi-fan Jia; Pei-yu Pu; Chun-sheng Kang
Journal:  Med Oncol       Date:  2009-08-29       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.